ImageneBio (IMA) Operating Income (2020 - 2024)
Historic Operating Income for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$28.1 million.
- ImageneBio's Operating Income fell 2833.21% to -$28.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$64.2 million, marking a year-over-year increase of 1487.22%. This contributed to the annual value of -$59.0 million for FY2024, which is 2180.41% up from last year.
- ImageneBio's Operating Income amounted to -$28.1 million in Q4 2024, which was down 2833.21% from -$2.0 million recorded in Q3 2024.
- In the past 5 years, ImageneBio's Operating Income registered a high of $2.8 million during Q4 2021, and its lowest value of -$28.1 million during Q4 2024.
- Its 5-year average for Operating Income is -$14.5 million, with a median of -$15.7 million in 2023.
- Its Operating Income has fluctuated over the past 5 years, first skyrocketed by 11071.66% in 2021, then crashed by 64133.24% in 2022.
- Over the past 5 years, ImageneBio's Operating Income (Quarter) stood at -$26.1 million in 2020, then surged by 110.72% to $2.8 million in 2021, then crashed by 641.33% to -$15.1 million in 2022, then crashed by 44.95% to -$21.9 million in 2023, then fell by 28.33% to -$28.1 million in 2024.
- Its Operating Income stands at -$28.1 million for Q4 2024, versus -$2.0 million for Q3 2024 and -$15.8 million for Q2 2024.